Next Investors logo grey

Crowd Media to assist leading UK-based consumer products business


Published 16-JUN-2020 12:09 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Crowd Media Holdings Limited (ASX:CM8 | FWB:CM3) has executed an exclusive and binding Marketing Services Agreement with London-based VITAL Innovations Ltd to market and sell key VITAL portfolio brands and products into the European market, excluding the UK.

This arrangement will leverage Crowd’s core strengths across the digital marketing, direct-to-consumer digital commerce, social media, influencer marketing and social commerce disciplines, driving web and mobile sales of VITAL products across Europe, enabling VITAL to roll out its award-winning brands into European Union markets.

Founded 40 years ago, VITAL is a UK-domiciled family-owned business that has created and launched a number of successful brands across a number of sectors including healthcare, consumer and water purification sectors.

The VITAL portfolio of brands includes Vital Baby, Vital Family & Super Safe.

Crowd and VITAL’s exclusive Marketing Service Agreement or what can also be termed as a European Union-based social media, influencer marketing and social commerce partnership will include the promotion and sale on a Direct to Consumer (D2C) model of some of VITAL’s brands into EU markets, while also developing and executing on all-encompassing digital marketing campaigns across Europe.

With regard to the financial implications of the proposed agreement, revenue share payments shall be payable on net sales generated for Vital Products sold as a result of Crowd’s marketing services as well as all sales generated through various websites controlled by Vital, regardless of whether such sales occur during or after the term of two years.

Crowd will be receiving 100% of Net Sales, or as agreed on a product-by-product basis.

Agreement draws on Crowd’s regional and demographic experience

This intended collaboration marks another milestone in the execution of the Crowd Media’s strategic vision as outlined by the company’s chairman Steven Schapera at the November 2019 AGM, when he highlighted the group’s plan to sell exemplary products integral to the lives of European-based millennials on a direct-to-consumer model.

02 - CM8.PNG

Crowd has deep experience in digital marketing to millennials in most European countries across 12 different languages, and the company will be using influencer and performance marketing strategies to drive VITAL sales.

Underlining the complementary characteristics between the two parties, Crowd chief executive Domenic Carosa said, “We are pleased to have executed an exclusive agreement with VITAL.

‘’They are a powerful, family-owned company and have been in business more than 40 years.

‘’Their portfolio brands are of special interest to Crowd because their target customer is almost always a millennial, perfectly matched to our social media and influencer marketing skills.

‘’We have already identified a number of VITAL key products and market segments in the healthcare and consumer space where we will focus our initial efforts.

‘’Crowd can really add value here, leveraging our five years of social media, social influencer and social commerce experience for the benefit of both parties.”

VITAL has agreed to subscribe for 5 million Crowd Media Holding Ltd shares at 3 cents per share, raising a total of $150,000 for general working capital purposes, further cementing the relationship between the parties.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.